Source: Genomeweb

Multiplicom: Multiplicom Wins €1.9M Grant to Develop Cancer Diagnosis, Monitoring Tech

Read full article »

Multiplicom's Competitors | Multiplicom's News | Multiplicom's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

CEO

Dirk Pollet

CEO Approval Rating

70/100

Multiplicom develops, manufactures and commercializes molecular diagnostic assays for clinical laboratories to diagnose the patients with genetic disease.